U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth...

Preview:

Citation preview

U.S. Genetic Testing Markets

New Technologies Drive Genetic Testing Acceptance, Spur Market Growth

“The genetic cancer testing market is ideal for micro-array/chip technologies. Once a patient has been diagnosed with a particular gene or genetic mutation, this technology has the potential to detect the levels

at which the gene is being expressed.”

Clinical Diagnostics Analyst Team

Frost & Sullivan

• Detailed insights into recent developments and trends

• Drivers, restraints, challenges, and strategic recommendations

• Analyst insights into ‘hot topics’ and emerging applications in the genetic testing market.

• Market-sizing and competitive analysis

• Market forecasts and opportunity analyses

• Quarterly assessments

• End-user analysis

Key Features

• Coverage: The United States

• Proven methodology using extensive primary and secondary data as well as research

• Focused information and strategies that cover business and technology issues

• Credible data and analyses that highlight industry dynamics

• Precise strategies to help you create winning business plans

What We Offer

Current Market Participants• Find out how you compare with the competition• Assess current and future drivers as well as restraints• Determine and exploit new market share opportunities

New Entrants • Analyze the associated challenges• Calculate timescales for strategy implementation• Position yourself to capitalize on the unmet needs of the market

Investment Community• Analyze long-term strategies of companies • Determine participants that will outperform the competition• Assess the attractiveness of investing in the market

Benefits

Affymetrix, Inc.Amersham Pharmacia Biotech/Amersham plcApplied Biosystems/AppleraARUP LaboratoriesAutoGen/ Iwata Co.Baylor College of MedicineBectonDickinisonBeckman Coulter, Inc.Bio-Rad Laboratories, Inc.Cambio, Ltd.CytocellF. Hoffmann-La Roche Ltd.GeneTestsGentra Systems, Inc.

Genzyme Corp.Johns Hopkins HospitalLaboratory Corp. of AmericaLI-COR, Inc.Lifecodes Corp.Mayo Medical LaboratoriesMyriad Genetics, Inc.Promega Corp.Qiagen (USA)Quest Diagnostics, Inc.Unilab Corp.Ventana Medical Systems, Inc.Visible Genetics, Inc.Vysis, Inc.

Key Market Participants

• Call toll free 877 GO FROST

(877.463.7876)

• Fax toll free 888.690.3329

• E-mail myfrost@frost.com

• Visit www.frost.com

For More Information

Recommended